1356053-57-0Relevant articles and documents
AZAINDAZOLE COMPOUNDS
-
Page/Page column 50; 51, (2012/02/02)
Disclosed are azaindazole compounds of Formula (I), or pharmaceutically acceptable salts thereof, wherein W is CR4 or N; and R1, R2, R3, and R4 are defined herein. Also disclosed are methods of using such compounds in the treatment of at least one CYP17 associated condition, such as, for example, cancer, and pharmaceutical compositions comprising such compounds.